A citation-based method for searching scientific literature

Tú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, Helen Tsimiklis, Zhi L Teo, Roger Li, Bernard J Pope, Mary Beth Terry, Saundra S Buys, Mary Daly, John L Hopper, Ingrid Winship, David E Goldgar, Daniel J Park, Melissa C Southey. Breast Cancer Res Treat 2015
Times Cited: 20







List of co-cited articles
104 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
520
75

A recurrent mutation in PALB2 in Finnish cancer families.
Hannele Erkko, Bing Xia, Jenni Nikkilä, Johanna Schleutker, Kirsi Syrjäkoski, Arto Mannermaa, Anne Kallioniemi, Katri Pylkäs, Sanna-Maria Karppinen, Katrin Rapakko,[...]. Nature 2007
325
50

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
677
45

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
Silvia Casadei, Barbara M Norquist, Tom Walsh, Sunday Stray, Jessica B Mandell, Ming K Lee, John A Stamatoyannopoulos, Mary-Claire King. Cancer Res 2011
174
40

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Bing Xia, Qing Sheng, Koji Nakanishi, Akihiro Ohashi, Jianmin Wu, Nicole Christ, Xinggang Liu, Maria Jasin, Fergus J Couch, David M Livingston. Mol Cell 2006
579
35

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
Sarah Reid, Detlev Schindler, Helmut Hanenberg, Karen Barker, Sandra Hanks, Reinhard Kalb, Kornelia Neveling, Patrick Kelly, Sheila Seal, Marcel Freund,[...]. Nat Genet 2007
446
35

A PALB2 mutation associated with high risk of breast cancer.
Melissa C Southey, Zhi L Teo, James G Dowty, Fabrice A Odefrey, Daniel J Park, Marc Tischkowitz, Nelly Sabbaghian, Carmel Apicella, Graham B Byrnes, Ingrid Winship,[...]. Breast Cancer Res 2010
89
30

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
Bing Xia, Josephine C Dorsman, Najim Ameziane, Yne de Vries, Martin A Rooimans, Qing Sheng, Gerard Pals, Abdellatif Errami, Eliane Gluckman, Julian Llera,[...]. Nat Genet 2007
345
30

Analysis of PALB2/FANCN-associated breast cancer families.
Marc Tischkowitz, Bing Xia, Nelly Sabbaghian, Jorge S Reis-Filho, Nancy Hamel, Guilan Li, Erik H van Beers, Lili Li, Tayma Khalil, Louise A Quenneville,[...]. Proc Natl Acad Sci U S A 2007
166
30

PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Feng Zhang, Jianglin Ma, Jiaxue Wu, Lin Ye, Hong Cai, Bing Xia, Xiaochun Yu. Curr Biol 2009
354
30

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Siân Jones, Ralph H Hruban, Mihoko Kamiyama, Michael Borges, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Emily Palmisano, Kieran Brune, Elizabeth M Jaffee,[...]. Science 2009
558
25


Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.
Priscilla H Fernandes, Jennifer Saam, Jenny Peterson, Elisha Hughes, Rajesh Kaldate, Shelly Cummings, Aaron Theisen, Sonia Chen, Jeffrey Trost, Benjamin B Roa. Cancer 2014
20
25

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients.
Agnieszka Dansonka-Mieszkowska, Anna Kluska, Joanna Moes, Michalina Dabrowska, Dorota Nowakowska, Anna Niwinska, Pawel Derlatka, Krzysztof Cendrowski, Jolanta Kupryjanczyk. BMC Med Genet 2010
86
25

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.
William D Foulkes, Parviz Ghadirian, Mohammed Reza Akbari, Nancy Hamel, Sylvie Giroux, Nelly Sabbaghian, Andrew Darnel, Robert Royer, Aletta Poll, Eve Fafard,[...]. Breast Cancer Res 2007
107
25

A general framework for estimating the relative pathogenicity of human genetic variants.
Martin Kircher, Daniela M Witten, Preti Jain, Brian J O'Roak, Gregory M Cooper, Jay Shendure. Nat Genet 2014
25

Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
Ana Blanco, Miguel de la Hoya, Ana Osorio, Orland Diez, María Dolores Miramar, Mar Infante, Cristina Martinez-Bouzas, Asunción Torres, Adriana Lasa, Gemma Llort,[...]. PLoS One 2013
36
25

Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.
Zhi L Teo, Daniel J Park, Elena Provenzano, Catherine A Chatfield, Fabrice A Odefrey, Tu Nguyen-Dumont, James G Dowty, John L Hopper, Ingrid Winship, David E Goldgar,[...]. Breast Cancer Res 2013
33
25

Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
María J García, Victoria Fernández, Ana Osorio, Alicia Barroso, Gemma Llort, Conxi Lázaro, Ignacio Blanco, Trinidad Caldés, Miguel de la Hoya, Teresa Ramón Y Cajal,[...]. Breast Cancer Res Treat 2009
74
25

Rare germline mutations in PALB2 and breast cancer risk: a population-based study.
Marc Tischkowitz, Marinela Capanu, Nelly Sabbaghian, Lili Li, Xiaolin Liang, Maxime P Vallée, Sean V Tavtigian, Patrick Concannon, William D Foulkes, Leslie Bernstein,[...]. Hum Mutat 2012
61
25


The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, Mark Daly,[...]. Genome Res 2010
20

The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
A-Yong Cao, Juan Huang, Zhen Hu, Wen-Feng Li, Zhong-Liang Ma, Li-Li Tang, Bin Zhang, Feng-Xi Su, Jie Zhou, Gen-Hong Di,[...]. Breast Cancer Res Treat 2009
67
20

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis.
Cezary Cybulski, Wojciech Kluźniak, Tomasz Huzarski, Dominika Wokołorczyk, Aniruddh Kashyap, Anna Jakubowska, Marek Szwiec, Tomasz Byrski, Tadeusz Dębniak, Bohdan Górski,[...]. Lancet Oncol 2015
100
20

Germline mutations in PALB2 in African-American breast cancer cases.
Yuan Chun Ding, Linda Steele, Li-Hao Chu, Karen Kelley, Helen Davis, Esther M John, Gail E Tomlinson, Susan L Neuhausen. Breast Cancer Res Treat 2011
26
20

Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.
Heide Hellebrand, Christian Sutter, Ellen Honisch, Eva Gross, Barbara Wappenschmidt, Christian Schem, Helmut Deissler, Nina Ditsch, Verena Gress, Marion Kiechle,[...]. Hum Mutat 2011
41
20

Novel germline PALB2 truncating mutations in African American breast cancer patients.
Yonglan Zheng, Jing Zhang, Qun Niu, Dezheng Huo, Olufunmilayo I Olopade. Cancer 2012
30
20

PALB2 mutations in German and Russian patients with bilateral breast cancer.
Natalia Bogdanova, Anna P Sokolenko, Aglaya G Iyevleva, Svetlana N Abysheva, Magda Blaut, Michael Bremer, Hans Christiansen, Margret Rave-Fränk, Thilo Dörk, Evgeny N Imyanitov. Breast Cancer Res Treat 2011
41
20

Penetrance analysis of the PALB2 c.1592delT founder mutation.
Hannele Erkko, James G Dowty, Jenni Nikkilä, Kirsi Syrjäkoski, Arto Mannermaa, Katri Pylkäs, Melissa C Southey, Kaija Holli, Anne Kallioniemi, Arja Jukkola-Vuorinen,[...]. Clin Cancer Res 2008
77
20

PALB2 regulates recombinational repair through chromatin association and oligomerization.
Shirley M-H Sy, Michael S Y Huen, Yongyou Zhu, Junjie Chen. J Biol Chem 2009
78
20

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.
Kai Wang, Mingyao Li, Hakon Hakonarson. Nucleic Acids Res 2010
15

A method and server for predicting damaging missense mutations.
Ivan A Adzhubei, Steffen Schmidt, Leonid Peshkin, Vasily E Ramensky, Anna Gerasimova, Peer Bork, Alexey S Kondrashov, Shamil R Sunyaev. Nat Methods 2010
15

The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.
Marketa Janatova, Zdenek Kleibl, Jana Stribrna, Ales Panczak, Kamila Vesela, Martina Zimovjanova, Petra Kleiblova, Pavel Dundr, Jana Soukupova, Petr Pohlreich. Cancer Epidemiol Biomarkers Prev 2013
36
15


PALB2: a novel inactivating mutation in a Italian breast cancer family.
Cristina Balia, Elisa Sensi, Grazia Lombardi, Manuela Roncella, Generoso Bevilacqua, Maria Adelaide Caligo. Fam Cancer 2010
27
15

Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.
Michelle W Wong-Brown, Kelly A Avery-Kiejda, Nikola A Bowden, Rodney J Scott. Int J Cancer 2014
12
25

Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and Singapore.
Sze Yee Phuah, Sheau Yee Lee, Peter Kang, In Nee Kang, Sook-Yee Yoon, Meow Keong Thong, Mikael Hartman, Jen-Hwei Sng, Cheng Har Yip, Nur Aishah Mohd Taib,[...]. PLoS One 2013
23
15

Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population.
Yessica Leyton, Patricio Gonzalez-Hormazabal, Rafael Blanco, Teresa Bravo, Ricardo Fernandez-Ramires, Sebastian Morales, Natalia Landeros, Jose M Reyes, Octavio Peralta, Julio C Tapia,[...]. BMC Cancer 2015
15
20

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.
Marc Tischkowitz, Nelly Sabbaghian, Anna M Ray, Ethan M Lange, William D Foulkes, Kathleen A Cooney. Prostate 2008
30
15

PALB2 and breast cancer: ready for clinical translation!
Melissa C Southey, Zhi L Teo, Ingrid Winship. Appl Clin Genet 2013
32
15

Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer.
Ana Blanco, Miguel de la Hoya, Judith Balmaña, Teresa Ramón y Cajal, Alex Teulé, María-Dolores Miramar, Eva Esteban, Mar Infante, Javier Benítez, Asunción Torres,[...]. Breast Cancer Res Treat 2012
39
15

Abridged adapter primers increase the target scope of Hi-Plex.
Tú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, Bernard J Pope, Graham G Giles, John L Hopper, Melissa C Southey, Daniel J Park. Biotechniques 2015
6
50

Cross-platform compatibility of Hi-Plex, a streamlined approach for targeted massively parallel sequencing.
Tú Nguyen-Dumont, Bernard J Pope, Fleur Hammet, Maryam Mahmoodi, Helen Tsimiklis, Melissa C Southey, Daniel J Park. Anal Biochem 2013
10
30

PALB2/FANCN: recombining cancer and Fanconi anemia.
Marc Tischkowitz, Bing Xia. Cancer Res 2010
129
15

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.
Ella R Thompson, Kylie L Gorringe, Simone M Rowley, Michelle W Wong-Brown, Simone McInerny, Na Li, Alison H Trainer, Lisa Devereux, Maria A Doyle, Jason Li,[...]. Breast Cancer Res 2015
26
15

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
Tuomas Heikkinen, Hanni Kärkkäinen, Kirsimari Aaltonen, Roger L Milne, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Heli Nevanlinna. Clin Cancer Res 2009
99
15

Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.
Yuan Chun Ding, Linda Steele, Chih-Jen Kuan, Scott Greilac, Susan L Neuhausen. Breast Cancer Res Treat 2011
83
15

Predicting functional effect of human missense mutations using PolyPhen-2.
Ivan Adzhubei, Daniel M Jordan, Shamil R Sunyaev. Curr Protoc Hum Genet 2013
15

PALB2 is an integral component of the BRCA complex required for homologous recombination repair.
Shirley M H Sy, Michael S Y Huen, Junjie Chen. Proc Natl Acad Sci U S A 2009
384
15

PALB2 self-interaction controls homologous recombination.
Rémi Buisson, Jean-Yves Masson. Nucleic Acids Res 2012
43
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.